Receptor-Mediated Redox Imbalance: An Emerging Clinical Avenue against Aggressive Cancers

Abstract excerpt

Cancer cells are more vulnerable to abnormal redox fluctuations due to their imbalanced antioxidant system, where cell surface receptors sense stress and trigger intracellular signal relay. As canonical targets of many targeted therapies, cell receptors sensitize the cells to specific drugs. On the other hand, cell target mutations are commonly associated with drug resistance. Thus, exploring effective...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Enzyme function and inhibition
• Share to Nanoplatforms for cancer theranostics
• Share to Plasma Applications and Diagnostics